Novartis fails to block first heart-failure generic by Indian rival

Delaware judge denies pharma giant’s request for injunction on rivals’ generic of Entresto | Novartis ‘unlikely to succeed’ in proving infringement | Lawsuit is one of several attempts to preserve exclusivity of the drug ahead of patent expiry and US price caps.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Generics

Novartis vows to challenge heart drug patent loss

11 July 2023 Decision affects a patent listed in the Orange Book | Generic drug makers have so far failed to secure approval for biosimilar versions of the blockbuster drug.

Generics

Novartis sued over blockbuster heart failure drug

30 August 2022 Pharma company facing lawsuit from two universities | Dispute centres on therapeutically effective co-crystals patent.

Big Pharma

Novartis sues Chinese firm over attempts to make generic heart failure drug

30 September 2021 Pharma giant Novartis has filed a patent suit against Crystal Pharmaceuticals after the rival sought to create a generic version of its heart failure drug Entresto.

More on this story

Generics

Novartis vows to challenge heart drug patent loss

11 July 2023 Decision affects a patent listed in the Orange Book | Generic drug makers have so far failed to secure approval for biosimilar versions of the blockbuster drug.

Generics

Novartis sued over blockbuster heart failure drug

30 August 2022 Pharma company facing lawsuit from two universities | Dispute centres on therapeutically effective co-crystals patent.

Big Pharma

Novartis sues Chinese firm over attempts to make generic heart failure drug

30 September 2021 Pharma giant Novartis has filed a patent suit against Crystal Pharmaceuticals after the rival sought to create a generic version of its heart failure drug Entresto.

More on this story

Generics

Novartis vows to challenge heart drug patent loss

11 July 2023 Decision affects a patent listed in the Orange Book | Generic drug makers have so far failed to secure approval for biosimilar versions of the blockbuster drug.

Generics

Novartis sued over blockbuster heart failure drug

30 August 2022 Pharma company facing lawsuit from two universities | Dispute centres on therapeutically effective co-crystals patent.

Big Pharma

Novartis sues Chinese firm over attempts to make generic heart failure drug

30 September 2021 Pharma giant Novartis has filed a patent suit against Crystal Pharmaceuticals after the rival sought to create a generic version of its heart failure drug Entresto.

More features

McGuireWoods expands team with ex-Novo Nordisk GC

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent

‘We took Ravgen head-on’: How we won zero-damages and others didn't

Bristol Myers Squibb leader named INTA 2025 president

Kathi Vidal to leave USPTO ahead of incoming Trump administration

Novartis fails to block first heart-failure generic by Indian rival

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features